Shao Y - Search Results

1

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes.

Chen X, Wang D, Liu J, Qiu J, Zhou J, Ying J, Shi Y, Wang Z, Lou H, Cui J, Zhang J, Liu Y, Zhao F, Pan L, Zhao J, Zhu D, Chen S, Li X, Li X, Zhu L, Shao Y, Shu Y. Chen X, et al. Among authors: shao y. J Immunother Cancer. 2021 Nov;9(11):e003214. doi: 10.1136/jitc-2021-003214. J Immunother Cancer. 2021. PMID: 34795005 Free PMC article.

2

Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GIST.

Xu H, Chen L, Shao Y, Zhu D, Zhi X, Zhang Q, Li F, Xu J, Liu X, Xu Z. Xu H, et al. Among authors: shao y. Mol Cancer Ther. 2018 Jan;17(1):290-296. doi: 10.1158/1535-7163.MCT-17-0436. Epub 2017 Nov 13. Mol Cancer Ther. 2018. PMID: 29133619

3

Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.

Zhang C, Zhang J, Xu FP, Wang YG, Xie Z, Su J, Dong S, Nie Q, Shao Y, Zhou Q, Yang JJ, Yang XN, Zhang XC, Li Z, Wu YL, Zhong WZ. Zhang C, et al. Among authors: shao y. J Thorac Oncol. 2019 Nov;14(11):1912-1923. doi: 10.1016/j.jtho.2019.07.031. Epub 2019 Aug 22. J Thorac Oncol. 2019. PMID: 31446140 Free PMC article.

4

Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.

Lan X, Bao H, Ge X, Cao J, Fan X, Zhang Q, Liu K, Zhang X, Tan Z, Zheng C, Wang A, Chen C, Zhu X, Wang J, Xu J, Zhu X, Wu X, Wang X, Shao Y, Ge M. Lan X, et al. Among authors: shao y. Cancer Sci. 2020 Jun;111(6):2163-2173. doi: 10.1111/cas.14389. Epub 2020 Apr 16. Cancer Sci. 2020. PMID: 32187423 Free PMC article.

5

Biomarkers of Osimertinib Response in Patients with Refractory, EGFR-T790M-positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study.

Xing L, Pan Y, Shi Y, Shu Y, Feng J, Li W, Cao L, Wang L, Gu W, Song Y, Xing P, Liu Y, Gao W, Cui J, Hu N, Li R, Bao H, Shao Y, Yu J. Xing L, et al. Among authors: shao y. Clin Cancer Res. 2020 Dec 1;26(23):6168-6175. doi: 10.1158/1078-0432.CCR-20-2081. Epub 2020 Aug 17. Clin Cancer Res. 2020. PMID: 32817079

6

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response.

Li J, Wei Q, Wu X, Sima J, Xu Q, Wu M, Wang F, Mou H, Hu H, Zhao J, Li D, Hu J, Zhang L, Zhu X, Chen L, Luo C, Yan J, He J, Ma Y, Shao Y, Wu W, Ying J. Li J, et al. Among authors: shao y. Clin Transl Med. 2020 Aug;10(4):e118. doi: 10.1002/ctm2.118. Clin Transl Med. 2020. PMID: 32898339 Free PMC article.

7

Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History.

He W, Leng X, Yang Y, Peng L, Shao Y, Li X, Han Y. He W, et al. Among authors: shao y. Onco Targets Ther. 2020 Sep 3;13:8795-8802. doi: 10.2147/OTT.S262512. eCollection 2020. Onco Targets Ther. 2020. PMID: 32943884 Free PMC article.

8

Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis.

Ding Y, Shao Y, Na C, Yin JC, Hua H, Tao R, Jiang Y, Hu R, He X, Miao C, Zhu D, Zhang Z. Ding Y, et al. Among authors: shao y. J Med Genet. 2022 Jan;59(1):10-17. doi: 10.1136/jmedgenet-2020-107083. Epub 2020 Oct 28. J Med Genet. 2022. PMID: 33115932

9

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.

Jin Y, Chen DL, Wang F, Yang CP, Chen XX, You JQ, Huang JS, Shao Y, Zhu DQ, Ouyang YM, Luo HY, Wang ZQ, Wang FH, Li YH, Xu RH, Zhang DS. Jin Y, et al. Among authors: shao y. Mol Cancer. 2020 Oct 30;19(1):154. doi: 10.1186/s12943-020-01274-7. Mol Cancer. 2020. PMID: 33126883 Free PMC article.

10

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial.

Chen X, Wu X, Wu H, Gu Y, Shao Y, Shao Q, Zhu F, Li X, Qian X, Hu J, Zhao F, Mao W, Sun J, Wang J, Han G, Li C, Xia Y, Seesaha PK, Zhu D, Li H, Zhang J, Wang G, Wang X, Li X, Shu Y. Chen X, et al. Among authors: shao q, shao y. J Immunother Cancer. 2020 Nov;8(2):e001240. doi: 10.1136/jitc-2020-001240. J Immunother Cancer. 2020. PMID: 33172881 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,470 results

Search Page

Filters